L. Miller

发表

Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.

C. Hogea, C. Acosta, J. Suaya, 2011, Microbial drug resistance.

The Alexander Project: the benefits from a decade of surveillance.

M. Jacobs, L. Miller, P. Appelbaum, 2005, The Journal of antimicrobial chemotherapy.

The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics.

R. Mera, D. Sahm, H. Amrine-Madsen, 2009, Microbial drug resistance.

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project.

R. Mera, L. Miller, A. White, 2005, Diagnostic microbiology and infectious disease.

The relative frequency of intraspecific lateral gene transfer of penicillin binding proteins 1a, 2b, and 2x, in amoxicillin resistant Streptococcus pneumoniae.

M. Stanhope, T. Lefébure, H. Amrine-Madsen, 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Risk factors for delayed immunization against measles, mumps, and rubella in Colorado two-year-olds.

W. Marine, R. E. Hoffman, L. Miller, 1994, Pediatrics.

Rapid Methods in Clinical Microbiology

L. Miller, D. Jungkind, B. Kleger, 1989, Advances in Experimental Medicine and Biology.

Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens

L. Koeth, L. Miller, N. Scangarella-Oman, 2017, Journal of Clinical Microbiology.

Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.

I. Phillips, A. King, L. Koeth, 2000, The Journal of antimicrobial chemotherapy.

Biological Warfare: Role of Scientific Societies

L. Miller, G. Cassell, R. Rest, 1992, Annals of the New York Academy of Sciences.

Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae

E. Hook, L. Miller, Jianzhong Huang, 2018, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

M. Hackel, D. Sahm, L. Miller, 2016, Antimicrobial Agents and Chemotherapy.

Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.

L. Miller, J. Poupard, S. Rittenhouse, 1996, Diagnostic microbiology and infectious disease.

Interpretive criteria for testing susceptibility of staphylococci to mupirocin

L. Miller, J. Poupard, J. Finlay, 1997, Antimicrobial agents and chemotherapy.

Neonatal HIV seroprevalence studies. A critique of national and international practices.

L. Miller, S. H. Isaacman, 1993, The Journal of legal medicine.

Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location

R. Mera, J. van Eldere, H. Amrine-Madsen, 2007, Antimicrobial Agents and Chemotherapy.

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.

Ronald N. Jones, R. Mera, T. Fritsche, 2008, Microbial drug resistance.

Antibacterial use and Streptococcus pneumoniae penicillin resistance: A temporal relationship model.

R. Mera, L. Miller, A. White, 2006, Microbial drug resistance.

Prevalence and Sequence Variation of Panton-Valentine Leukocidin in Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the United States

J. Suaya, R. Mera, H. Amrine-Madsen, 2011, Journal of Clinical Microbiology.

Evolving concepts of pharmaceutical company-sponsored surveillance studies.

L. Koeth, L. Miller, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniaeIsolates from across Europe, North America, and South America

J. Karlowsky, D. Hoban, L. Miller, 2000, Antimicrobial Agents and Chemotherapy.

Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time.

R. Mera, D. Sahm, H. Amrine-Madsen, 2011, Microbial drug resistance.

Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004 (cid:1)

W. Halsey, R. Mera, H. Amrine-Madsen, 2008 .

Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States.

R. Mera, D. Sahm, H. Amrine-Madsen, 2010, Microbial drug resistance.

In Vitro Activity and Microbiological Efficacy of Gepotidacin from a Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients with Acute Bacterial Skin and Skin Structure Infections

James R. Brown, S. Van Horn, L. Miller, 2019, Antimicrobial Agents and Chemotherapy.

β-Lactamase-inhibitor combinations in the 21st century: current agents and new developments

D. Payne, L. Miller, K. Ratnam, 2001 .

A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.

R. L. Kaplan, L. Miller, J. Poupard, 1995, Diagnostic microbiology and infectious disease.

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

James R. Brown, G. P. Livi, S. Van Horn, 2014, Antimicrobial Agents and Chemotherapy.

Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Global Clinical Trials

R. Goering, S. Van Horn, H. Amrine-Madsen, 2008, Journal of Clinical Microbiology.

A 5-Year Surveillance Study of 44,691 Isolates ofHaemophilus influenzae Project Beta-Alert 1993–1997

R. L. Kaplan, L. Miller, J. Poupard, 1999, Antimicrobial Agents and Chemotherapy.

Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development.

Michael J. Italia, Tristan Lefébure, M. Stanhope, 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study

D. Hoban, G. Zhanel, L. Miller, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

A review of the antimicrobial activity of clavulanate.

L. Miller, J. Poupard, Jane Finlay, 2003, The Journal of antimicrobial chemotherapy.

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2001, Diagnostic microbiology and infectious disease.

Evaluation of two commercially available test methods to determine the feasibility of testing for respiratory syncytial virus in a community hospital laboratory.

J. White, L. Miller, J. Poupard, 1988, American journal of clinical pathology.

The growth and survivability of Streptococcus pneumoniae clinical isolates subjected to various environmental conditions.

L. Miller, G. Mazzola, J. Poupard, 2003, Diagnostic microbiology and infectious disease.

Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae

D. Holmes, L. Miller, Jianzhong Huang, 2015, Antimicrobial Agents and Chemotherapy.

Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments.

D. Payne, L. Miller, K. Ratnam, 2001, Current opinion in pharmacology.

Comparison of partner notification at anonymous and confidential HIV test sites in Colorado.

N. E. Spencer, L. Miller, R. E. Hoffman, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Molecular Evolution Perspectives on Intraspecific Lateral DNA Transfer of Topoisomerase and Gyrase Loci in Streptococcus pneumoniae, with Implications for Fluoroquinolone Resistance Development and Spread

Michael J. Italia, James R. Brown, M. Stanhope, 2005, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Surveillance of Amoxicillin-Clavulanic Acid and Four Oral Comparators Against 21,232 Clinical Isolates from Europe

D. Hoban, G. Zhanel, L. Miller, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.

L. Koeth, L. Miller, N. Scangarella-Oman, 2021, Diagnostic microbiology and infectious disease.

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.

D. Hoban, L. Miller, J. Poupard, 2004, International journal of antimicrobial agents.

Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004

W. Halsey, R. Mera, J. van Eldere, 2008, Antimicrobial Agents and Chemotherapy.

Escherichia coli ATCC 35218 as a Quality Control Isolate for Susceptibility Testing of Haemophilus influenzae with Haemophilus Test Medium

L. Miller, J. Poupard, C. Jakielaszek, 1999, Antimicrobial Agents and Chemotherapy.

A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300.

Nicolas Guex, N. Guex, J. Word, 2008, The Journal of infectious diseases.

Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.

L. Miller, J. Poupard, D. Felmingham, 1999, The Journal of antimicrobial chemotherapy.

Determination of Disk Diffusion and MIC Quality Control Ranges for GSK1322322, a Novel Peptide Deformylase Inhibitor

Ronald N. Jones, Helio S. Sader, L. Miller, 2011, Journal of Clinical Microbiology.

Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location (cid:1)

R. Mera, H. Amrine-Madsen, L. Miller, 2007 .

Stability of amoxicillin-clavulanate in BACTEC medium determined by high-performance liquid chromatography and bioassay

L. Miller, J. Poupard, T. Moore, 1996, Journal of clinical microbiology.

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2003, International journal of antimicrobial agents.

Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development.

Michael J. Italia, M. Stanhope, T. Lefébure, 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.

C. Hogea, C. Acosta, J. Suaya, 2011, Microbial drug resistance.